alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


     The  undersigned  hereby  certify,  pursuant to 18 U.S.C.  Section 1350, as
adopted pursuant to Section 906 of the  Sarbanes-Oxley Act of 2002, that, to the
undersigned's  best knowledge and belief,  the Quarterly Report on Form 10-Q for
the Geodyne Energy Income  Limited  Partnership  II-F  ("Issuer") for the period
ending  September 30, 2004 as filed with the Securities and Exchange  Commission
on the date hereof (the "Report"):

      (a)   fully complies with the requirements of section 13(a) or 15(d) of
            the Securities Exchange Act of 1934; and
      (b)   the  information  contained in the Report  fairly  presents,  in all
            material respects, the financial condition and results of operations
            of the Issuer.

     Dated this 12th day of November, 2004.

                                    GEODYNE ENERGY INCOME LIMITED
                                    PARTNERSHIP II-F
                                    ("Issuer")

                                    //s// Dennis R. Neill
                                    -----------------------------------
                                    Dennis R. Neill
                                    President (Chief Executive Officer)

                                    //s// Craig D. Loseke
                                    -----------------------------------
                                    Craig D. Loseke
                                    Chief Accounting Officer
                                    (Chief Financial Officer)


      A signed  original of this written  statement  required by Section 906 has
been  furnished to Geodyne  Energy Income  Limited  Partnership II-F and will be
retained by Geodyne Energy Income Limited  Partnership II-F and furnished to the
Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>

This schedule contains  financial  information  extracted from the Corporation's
financial  statements  as of and for the year ended  December 31, 1997,  and the
accompanying footnotes and is qualified in its entirety by the reference to such
financial statements.

</LEGEND>
<CIK> 0000012355
<NAME> THE BLACK & DECKER CORPORATION
<MULTIPLIER> 1,000
       
<S>                                        <C>
<PERIOD-TYPE>                              12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         246,800
<SECURITIES>                                         0
<RECEIVABLES>                                  931,400<F1>
<ALLOWANCES>                                    47,800
<INVENTORY>                                    774,700
<CURRENT-ASSETS>                             2,078,800
<PP&E>                                         915,100<F2>
<DEPRECIATION>                               1,002,800
<TOTAL-ASSETS>                               5,360,700
<CURRENT-LIABILITIES>                        1,372,600
<BONDS>                                      1,623,700
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        47,400
<OTHER-SE>                                   1,744,000
<TOTAL-LIABILITY-AND-EQUITY>                 5,360,700
<SALES>                                      4,940,500
<TOTAL-REVENUES>                             4,940,500
<CGS>                                        3,169,200
<TOTAL-COSTS>                                4,451,200
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             132,700
<INCOME-PRETAX>                                349,500
<INCOME-TAX>                                   122,300
<INCOME-CONTINUING>                            227,200
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   227,200
<EPS-PRIMARY>                                     2.40<F3>
<EPS-DILUTED>                                     2.35
<FN>
<F1>Represents net trade receivables.
<F2>Represents net property, plant, and equipment.
<F3>Represents basic earnings per share.
</FN>
        

</TABLE>
[Federal Register Volume 74, Number 122 (Friday, June 26, 2009)]
[Notices]
[Page 30598]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-15077]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Conflict Review.
    Date: July 8, 2009.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Joann McConnell, PhD, Scientific Review 
Administrator, Scientific Review Branch, NIH/NINDS/Neuroscience 
Center, 6001 Executive Blvd., Suite 3208, Msc 9529, Bethesda, MD 
20892-9529, (301) 496-5324, <a href="/cdn-cgi/l/email-protection#b6dbd5d5d9d8d8d3dcf6d8dfd8d2c598d8dfde98d1d9c0"><span class="__cf_email__" data-cfemail="dbb6b8b8b4b5b5beb19bb5b2b5bfa8f5b5b2b3f5bcb4ad">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: June 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15077 Filed 6-25-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### Gene S. GROVES, Claimant-Appellant, v. R. James NICHOLSON, Secretary of Veterans Affairs, Respondent-Appellee.

No. 06-7048.

United States Court of Appeals, Federal Circuit.

June 14, 2006.

Before NEWMAN, RADER, and GAJARSA, Circuit Judges.

JUDGMENT

PER CURIAM

This CAUSE having been heard and considered, it is ORDERED and AD*1005JUDGED: *AFFIRMED. See*Fed. Cir. R. 36
SCPW

- 2 4

- 0000 485

IN THE SUPREME COURT OF THE STATE OF HAWAI ʻ I

________________________________________________________________ SILAS VALDEZ , Petitioner,

vs.

THE HONORABLE ROWENA A. SOMERVILLE , Judge of the Circuit Court of the First Circuit, State of Hawai ʻ i , Respondent Judge ,
and

STATE OF HAWAI ʻ I , Respondent

.

________________________________________________________________ ORIGINAL PROCEEDING ( CASE NO. 1CPN

- 23

- 0000023 )

ORDER DENYING PETITION WITHOUT PREJUDICE (By: Recktenwald , C.J., McKenna, Eddins, Ginoza, and Devens, JJ

. )
Upon consideration of the letter filed on July 22 , 2024 , which we construe as a petition for a writ of mandamus, and the
record, the amount of time that has passed without court action
does not amount to a flagrant and manifest abuse of discretion,
nor a refusal to act on a subject before the court under
circumstances in which the court has a legal duty to act

. An Electronically Filed Supreme Court SCPW-24-0000485 30-AUG-2024 01:25 PM Dkt. 5 ODDP2 extraordinary writ is unwarranted. See Womble Bond Dickinson

(US) LLP v. Kim , 153 Haw ai ʻ i 307, 319, 537 P.3d 1154, 1166

(2023)

.

I t is ordered that the petition is denied without
prejudice

. It is further ordered that the appellate clerk shall serve
a copy of the July 22, 2024 letter and this order on the
Respondent Judge.

DATED: Honolulu, Hawai ʻ i, August 30 , 2024

. /s/ Mark E. Recktenwald
/s/ Sabrina S. McKenna
/s/ Todd W. Eddins
/s/ Lisa M. Ginoza
/s/ Vladimir P. Devens
IV 

116TH CONGRESS 

1ST SESSION H. RES. 47 

Condemning all forms of anti-Semitism. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 16, 2019 

Mr. WRIGHT (for himself, Mr. MEADOWS, Mr. HICE of Georgia, Mr. DUNCAN, 

and Mr. GRIFFITH) submitted the following resolution; which was referred to the Committee on the Judiciary 

RESOLUTION 

Condemning all forms of anti-Semitism. 

Whereas, in 2017, reported anti-Semitic incidents increased 

57 percent over the previous year, according to the AntiDefamation League’s 2017 Audit of Anti-Semitic Incidents, which describes trends such as the 86 percent increase in reported incidents of vandalism and the 41 percent increase in reported incidents of harassment; 

Whereas, in 2017, anti-Semitic incidents at institutions of 

higher education nearly doubled compared to the number 

of those incidents in 2016, and during the 2016–2017 

school year there was an increase in White supremacist 

activity on college campuses across the United States, according to the Anti-Defamation League; and 

Whereas the perpetrator of the shooting that killed 11 Jewish 

worshippers at Tree of Life synagogue in Pittsburgh, 


kjohnson on DSK79L0C42 with BILLS
2 

•HRES 47 IH 

Pennsylvania, on October 27, 2018, accused Jews of 

‘‘waging a propaganda war against Western civilization’’ 

and ‘‘committing genocide’’ against Whites by promoting 

immigration and refugee resettlement, and accused the 

President of being ‘‘a globalist, not a nationalist’’ because 

of the ‘‘infestation’’ of Jews: Now, therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) affirms that the United States stands 

3 united in condemning anti-Semitism in any form; 

4 (2) supports the right of Americans to freely 

5 exercise their religious beliefs and rejects all forms 

6 of terror and hate; 

7 (3) condemns all manifestations of expressions 

8 of racism, anti-Semitism, and ethnic or religious in9 tolerance; and 

10 (4) calls on Federal law enforcement officials, 

11 working with State and local officials— 

12 (A) to expeditiously investigate all credible 

13 reports of hate crimes and incidents and threats 

14 against the Jewish community in the United 

15 States; and 

16 (B) to hold the perpetrators of those 

17 crimes, incidents, or threats accountable and 

18 bring such perpetrators to justice. 

Æ 


kjohnson on DSK79L0C42 with BILLS
Exhibit 31.2

CERTIFICATION

PURSUANT TO 17 CFR 240.13a-14

PROMULGATED UNDER

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Frederick D. Furry, certify that:



|1. | I have reviewed this annual report on Form 10-K/A of Biolase, Inc.; and
|-- | -----------------------------------------------------------------------



|2. | Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report.
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: July 6, 2012



|                                                                                         
|-----------------------------------------------------------------------------------------
|/s/ Frederick D. Furry                                                                   
|Frederick D. Furry
Chief Financial Officer and principal financial and
accounting officer
Exhibit 23.01

                       CONSENT OF INDEPENDENT ACCOUNTANTS


     We consent to the incorporation by reference in the registration statements
of Digital Link  Corporation and  Subsidiaries on Form S-8 (File Nos.  33-74666,
33-95176 and  333-27855) of our reports dated January 20, 1998, on our audits of
the  consolidated  financial  statements  and  financial  statement  schedule of
Digital Link  Corporation and Subsidiaries as of December 31, 1997 and 1996, and
for the years ended December 31, 1997,  1996 and 1995 which reports are included
in this Annual Report on Form 10-K.




 
                                                COOPERS & LYBRAND L.L.P.





San Jose, California
March 25, 1998
***EXHIBIT 32***

 

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the report on Form 10-QSB/A of High End Ventures, Inc. for the quarterly period ended June 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (“Report”), I, Nadir Walji, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

|   | (1) | This Report complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|-----|------------------------------------------------------------------------------------------------------------------|

|   | (2) | The information contained in this Report fairly represents, in all material respects, the financial condition of the small business issuer at the end of the period covered by this Report and results of operations of the small business issuer for the period covered by this Report. |
|--------|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

 

/s/ Nadir Walji

Nadir Walji

Chief Executive Officer and Chief Financial Officer

September 18, 2007

 

This certification accompanies this Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the small business issuer for the purposes of §18 of the Securities Exchange Act of 1934, as amended. This certification shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Report), irrespective of any general incorporation language contained in such filing.

 

A signed original of this written statement required by §906 has been provided to the small business issuer and will be retained by the small business issuer and furnished to the Securities and Exchange Commission or its staff upon request.
***E******xhibit******31***

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIE****F FINANCIAL OFFICER****PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

     

I, Nadir Waljicertify that:                 1. I have reviewed this report on Form 10-QSB (“Report”) of High End Ventures, Inc.;                 2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;                 3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the period presented in this Report;                 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e))for the small business issuer and have:                 a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the small business issuer is made known to me by others within those entities, particularly during the period in which this Report is being prepared;                 b) Evaluated the effectiveness of the small business issuer's disclosure controls and procedures and presented in this Report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and                 c) Disclosed in this Report any change in the small business issuer’s internal control over financial reporting that occurred during the small business issuer’s most recent fiscal quarter (the small business issuer’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation, to the small business issuer's auditors and the audit committee ofthesmall business issuer's board of directors (or persons performing the equivalent functions):                 a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize and report financial information; and                 b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuer's internal controls over financial reporting.

Date:May12, 2008

/s/ Nadir Walji

Nadir Walji

Chief Executive Officer and Chief Financial Officer

24

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel; Extramural Associates Research Development Award (EARDA).                    

*Date:*                         July 9, 2009.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015.                    

*Contact Person:*                         Carla T. Walls, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health, and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 435-6898,                         *wallsc@mail.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: June 5, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-13760 Filed 6-11-09; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000854062
<NAME> GEODYNE ENERGY INCOME LIMITED PARTNERSHIP II-H
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                         253,505
<SECURITIES>                                         0
<RECEIVABLES>                                  216,854
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               470,359
<PP&E>                                       6,904,226
<DEPRECIATION>                               5,433,874
<TOTAL-ASSETS>                               1,978,933
<CURRENT-LIABILITIES>                           36,016
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,928,778
<TOTAL-LIABILITY-AND-EQUITY>                 1,978,993
<SALES>                                        360,814
<TOTAL-REVENUES>                               362,523
<CGS>                                                0
<TOTAL-COSTS>                                  952,430
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (589,907)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (589,907)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (589,907)
<EPS-PRIMARY>                                   (6.48)
<EPS-DILUTED>                                        0
        

</TABLE>